Evidence map›Paper›PMID 41433102›Full record

ArticleJournal of applied clinical medical physics2026

3D printed collimators and dosimetry for spatially fractionated radiation therapy.

MacKenzie R Coon-Haworth, Justin B Geise, Thirumurugan Elango, Chandler J Zaugg, Jessica L Veenstra, Justina J Riffell, Anna Polkowski, Oluwaseyi M Oderinde, Judith N Rivera, Matthew L Scarpelli

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

MacKenzie R Coon-HaworthSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Justin B GeiseSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Thirumurugan ElangoDepartment of Medical Physics, Precess Medical Derivatives, Short Hills, New Jersey, USA.
Chandler J ZauggSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Jessica L VeenstraSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Justina J RiffellSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Anna PolkowskiSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Oluwaseyi M OderindeSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.
Judith N RiveraIndiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Matthew L ScarpelliSchool of Health Sciences, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0003-0735-1682

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDREW D MESECAR · 1985 to 2026
$43.4M
NCI NIH HHS P30 CA023168NIH HHS P30 CA023168
6 · The paper itself

Abstract

backgroundSpatially fractionated radiation therapy (SFRT) has shown incredible potential in sparing normal tissues and activating mechanisms of tumor control distinct from conventional radiotherapy. However, the optimal spatial configuration of SFRT as well as the optimal peak and valley dose values have not been established. This poses a barrier to widespread clinical implementation and efficacy. PURPOSE: To facilitate greater SFRT optimization, this work establishes a simple, readily customizable, and cost-effective approach for fabricating SFRT collimators with different spatial configurations as well as peak and valley dose values.

methodsThe approach involves fabrication of custom SFRT collimators, each consisting of a 3D-printed plastic shell filled with tungsten. Once fabricated, the collimator dosimetry is characterized using a combination of Gafchromic film and ion chamber measurements. Monte Carlo simulations are used to verify SFRT dosimetry and assess positional uncertainties. The collimators are applied in preclinical mouse experiments demonstrating how they can be used to deliver SFRT.

resultsFive collimators were fabricated for use at kilovoltage energies and one collimator was fabricated for use at megavoltage energies. Across all collimators, the peak widths ranged from 1.2 to 10.1 mm and the valley widths ranged from 1.1 to 10.6 mm. For the kilovoltage collimators, the highest peak-to-valley dose ratio was 32.4 at the surface and this dropped to 29.5 at 10 mm depth. For the megavoltage collimator, at 95 cm SSD, the peak-to-valley dose ratio was 2.7 at 15 mm depth and this dropped to 2.2 at 100 mm depth. In the mouse experiments, out of multiple SFRT parameters, the mean tumor valley dose had the strongest correlation with change in tumor volume (p = 0.02). The Monte Carlo simulations indicated a 5 mm translation of the mouse tumor relative to the beam led to a 44.8% change in the mean tumor dose, underlying the importance of precise positioning for SFRT.

conclusionsThis work establishes a novel approach for custom 3D printing of SFRT collimators and their subsequent characterization. The developed collimators are capable of SFRT delivery at both kilovoltage and megavoltage photon beam energies. This approach facilitates patient specific customization as well as optimization of the peak and valley doses for more effective SFRT.

Indexed as

NeoplasmsPhantoms, ImagingPrinting, Three-DimensionalRadiometryRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedAnimalsDose Fractionation, RadiationHumansMiceMonte Carlo MethodRadiotherapy Dosage3D printingMonte Carlospatially fractionated radiation therapyTOPAS

Identifiers

PMID41433102
PMCPMC12724578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.